Bitcoin has fallen to a seven-month low, nearing the $80,000 mark. This decline mirrors a wider sell-off in cryptocurrencies, driven by investor concerns over tech valuations and US interest rates. The market sentiment has turned fragile, impacting high-flying AI stocks. Bitcoin has erased its year-to-date gains, raising worries about further significant losses for the digital asset.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026